GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a prominent focus in medical investigation, largely due to its impressive impact on treating diseases such as second type diabetes and weight gain. New trials have demonstrated that more than glucose management, GLP-1 medications offer promise for cardiovascular functi